Zosano Pharma Corporation announced the appointment of Kathy McGee, an accomplished biopharmaceutical executive, to its board of directors. Ms. McGee brings experience from a broad range of leadership roles across operations, strategic planning, manufacturing and supply chain management, quality and regulatory affairs and new product development. Ms. McGee is currently chief operating officer of AVITA MEDICAL, where she is responsible for manufacturing operations, facilities and engineering, supply chain, program management, new product development, information technology and quality and regulatory affairs. Ms. McGee was appointed as a Class II director, to serve for an initial term expiring at the Company’s 2022 annual meeting of stockholders and until her successor is duly elected and qualified or until her earlier death, resignation or removal. Ms. McGee was also appointed to serve as a member of the Audit Committee of the Board.